Troglitazone inhibits α1-adrenoceptor-induced DNA synthesis in vascular smooth muscle cells

European Journal of Pharmacology

Volumn 374, Issue 1, 1999, Pages 127-135

  Nishio, Eisuke ^a   Watanabe, Yasuhiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

1 adrenoceptor; c fos; Smooth muscle cell vascular; SRE (serum response element); SRF (serum response factor); TCF (ternary complex factor); Troglitazone

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; ORAL ANTIDIABETIC AGENT; TROGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CHROMAN DERIVATIVE; DNA; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PHENYLEPHRINE; PHOSPHOLIPASE C; PROTEIN KINASE (CALCIUM,CALMODULIN); SERUM RESPONSE FACTOR; THIAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; DNA SYNTHESIS INHIBITION; GENE EXPRESSION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SERUM RESPONSIVE ELEMENT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; ONCOGENE; PHYSIOLOGY; TRANSACTIVATION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELLS, CULTURED; CHROMANS; DNA; DNA-BINDING PROTEINS; GENES, FOS; HYPOGLYCEMIC AGENTS; MUSCLE, SMOOTH, VASCULAR; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PHENYLEPHRINE; PHOSPHOLIPASE C; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; RESPONSE ELEMENTS; SERUM RESPONSE FACTOR; THIAZOLES; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS);

EID: 0032589055     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00271-X     Document Type: Article

References (26)

1. Anofossi G., Trovati M. Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur. J. Clin. Invest. 26:1996;353-370.
2. Barman S.A. Effect of catecholamines on pulmonary circulation at elevated vascular tone. J. Appl. Physiol. 78:1995;1452-1458.
3. Bennett M.R., Anglin S., McEwan J.R., Jagoe R., Newby A.C., Evan G.I. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J. Clin. Invest. 93:1994;820-828.
4. Campan M., Desgranges C., Gadeau A.P., Millet D., Belloc F. Cell cycle dependent gene expression in quiescent stimulated and asynchronously cycling arterial smooth muscle cells in culture. J. Cell. Physiol. 150:1992;493-500.
5. Chambers D.A., Cohen R.L., Perlman R.L. Neuroimmune modulation: signal transduction and catecholamies. Neurochem. Int. 22:1993;95-110.
6. Ciffi C.L., Garay M., Johnston J.F., McGraw K., Boggs R.T., Hreniuk D., Monia B.P. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation. Mol. Pharmacol. 51:1997;383-389.
7. Coolican S.A., Samuel D.S., Ewton D.Z., McWade F.J., Florini J.R. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signalling pathways. J. Biol. Chem. 272:1997;6653-6662.
8. Graf K., Xi X.P., Hsueh W.A., Law R.E. Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells. FEBS Lett. 400:1997;119-121.
9. Hill C.S., Marais R., John S., Wynne J., Dalton S., Treisman R. Functional analysis of a growth factor-responsive transcription factor complex. Cell. 73:1993;395-406.
10. Hill C.S., Wynne J., Triesman R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell. 81:1995;1159-1170.
11. Jankenecht R., Nordheim A. Gene regulation by Ets proteins. Biochim. Biophys. Acta. 1155:1993;346-356.
12. Kumar S., Boulton A.J., Beck-Nielsen H., Berthezene F., Muggeo M., Persson B., Spinas G.A., Donoghue S., Lettis S., Stewart-Long P. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia. 39:1996;701-709.
13. Law R.E., Meehan W.P., Xi X.P., Graf K., Wuthrich D.A., Coats W., Faxon D., Hsueh W.A. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98:1996;1905-1987.
14. Monia B.P., Johnston J.F., Geiger T., Muller M., Fabbro D. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase. Nat. Med. 2:1996;634-635.
15. Nishio E., Watanabe Y. Glucose-induced down-regulation of NO production and inducible NOS expression in cultured rat aortic vascular smooth muscle cells: role of protein kinase C. Biochem. Biophys. Res. Commun. 229:1996;857-863.
16. Nishio E., Watanabe Y. Transforming growth factor beta is a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for catalase activity and glutathione peroxidase activity. Biochem. Biophys. Res. Commun. 232:1997;1-4.
17. Nishio E., Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in alpha1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br. J. Pharmacol. 121:1997;665-670.
18. Nishio E., Nakata H., Arimura S., Watanabe Y. Alpha-1 adrenergic receptor stimulation causes arachidonic acid release through pertussis toxin-sensitive GTP-binding protein and JNK activation in rabbit aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 219:1996;277-282.
19. Noveral J.P., Grunstein M.M. Adrenergic receptor-mediated regulation of cultured rabbit airway smooth muscle cell proliferation. Am. J. Physiol. 267:1994;L291-L299.
20. Okazaki M., Hu Z.W., Fujinaga M., Hoffman B.B. Alpha 1 adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells. J. Clin. Invest. 94:1994;210-218.
21. Sah V.P., Hoshijima M., Chien K.R., Brown J.H. Rho is required for Galphaq and alpha1-adrenergic receptor signalling in cardiomyocytes. Dissociation of Ras and Rho pathways. J. Biol. Chem. 271:1996;31185-31190.
22. Seth A., Gonzalez F.A., Gupta S., Raden D.L., Davis R.J. Signal transduction within the nucleus by mitogen-activated protein kinase. J. Biol. Chem. 267:1992;24796-24804.
23. Treisman R. The SRE: a growth factor responsive transcriptional regulator. Semin. Cancer Biol. 1:1990;47-58.
24. Triesman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:1994;96-101.
25. Yu S.M., Tsai S.Y., Guh J.H., Ko F.N., Teng C.M., Ou J.T. Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation. 94:1996;547-554.
26. Whitmarsh A.J., Shore P., Sharrocks A.D., Davis R.J. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 269:1995;403-407.